Cargando…

Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab

Migraine pain is frequently accompanied by cranial hyperalgesia and allodynia. Calcitonin gene-related peptide (CGRP) is implicated in migraine pathophysiology but its role in facial hypersensitivity is not entirely clear. In this study, we investigated if the anti-CGRP monoclonal antibody fremanezu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benedicter, Nicola, Messlinger, Karl, Vogler, Birgit, Mackenzie, Kimberly D., Stratton, Jennifer, Friedrich, Nadine, Dux, Mária
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204392/ https://www.ncbi.nlm.nih.gov/pubmed/37218978 http://dx.doi.org/10.3390/neurolint15020039

Ejemplares similares

The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022)

The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
por: Vogler, Birgit, et al.
Publicado: (2023)

CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater
por: Risch, Miriam, et al.
Publicado: (2021)

Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
por: Ohlsson, Lena, et al.
Publicado: (2018)

CGRP measurements in human plasma – a methodological study
por: Messlinger, Karl, et al.
Publicado: (2021)

Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels
por: Kleeberg-Hartmann, Johanna, et al.
Publicado: (2021)

Role Of Cgrp In Sensitization Of Dura Mater
por: Messlinger, K.
Publicado: (2001)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Migraine therapeutics differentially modulate the CGRP pathway
por: Bhakta, Minoti, et al.
Publicado: (2021)

Antinociceptive effects of dexmedetomidine via spinal substance P and CGRP
por: Li, Ruiqin, et al.
Publicado: (2015)

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
por: Messlinger, Karl
Publicado: (2018)

The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?
por: Messlinger, Karl
Publicado: (2021)

Fremanezumab for migraine
Publicado: (2020)

Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge
por: Frank, Florian, et al.
Publicado: (2022)

Fremanezumab: First Global Approval
por: Hoy, Sheridan M.
Publicado: (2018)

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
por: Straube, Andreas, et al.
Publicado: (2023)

Correction to: Fremanezumab: First Global Approval
por: Hoy, Sheridan M.
Publicado: (2019)

Fremanezumab in the treatment of migraines: evidence to date
por: Robblee, Jennifer, et al.
Publicado: (2019)

Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
por: Kageneck, Charlotte, et al.
Publicado: (2014)

TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches
por: Dux, Mária, et al.
Publicado: (2020)

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020)

Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
por: Root, Shane, et al.
Publicado: (2023)

Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
por: Kawamura, Shin, et al.
Publicado: (2022)

Learning from EMG: semi-automated grading of facial nerve function
por: Holze, Magdalena, et al.
Publicado: (2022)

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
por: Fiedler‐Kelly, Jill, et al.
Publicado: (2020)

Fremanezumab for migraine prevention: more effective, less costly
Publicado: (2020)

One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
por: Katsuki, Masahito, et al.
Publicado: (2023)

Excitatory Effects of Calcitonin Gene-Related Peptide (CGRP) on Superficial Sp5C Neurons in Mouse Medullary Slices
por: Zheng, Fang, et al.
Publicado: (2021)

Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier
por: Noseda, Rodrigo, et al.
Publicado: (2019)

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
por: Lipton, Richard B., et al.
Publicado: (2020)

CGRP and CGRP receptors in human and rhesus monkey cerebellum
por: Eftekhari, S, et al.
Publicado: (2013)

H(2)S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway
por: Eberhardt, Mirjam, et al.
Publicado: (2014)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment
por: Seiler, Kristin, et al.
Publicado: (2013)

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days
por: VanderPluym, Juliana, et al.
Publicado: (2018)

Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine
por: Fiedler‐Kelly, Jill B., et al.
Publicado: (2019)

A Semi-automated Organoid Screening Method Demonstrates Epigenetic Control of Intestinal Epithelial Differentiation
por: Ostrop, Jenny, et al.
Publicado: (2021)

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

Involvement of TRPA1 receptors in meningeal blood flow induced by formation of nitroxyl (NO-/HNO)
por: Dux, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ppk1mh4nkr32cfk3ntk4e8burl